Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Top 5 Health Care Stocks That May Rally

Published 03/02/2023, 18:35
Updated 03/02/2023, 19:40
© Reuters Top 5 Health Care Stocks That May Rally

© Reuters Top 5 Health Care Stocks That May Rally

Benzinga - The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30.

Here’s the latest list of major oversold players in this sector, having an RSI near or below 30.

Third Harmonic Bio, Inc. (NASDAQ: THRD)

  • Morgan Stanley recently downgraded Third Harmonic Bio from Overweight to Equal-Weight and lowered the price target from $34 to $5. The company’s stock has a 52-week low of $3.89 .
  • RSI Value: 28.71
  • THRD Price Action: Shares of Third Harmonic Bio gained 1.1% to trade at $4.50 on Friday.
AstraZeneca PLC (NASDAQ: AZN)
  • US approved AstraZeneca, Amgen's Tezspire (tezepelumab) for self-administration in a pre-filled, single-use pen for patients 12 years and older with severe asthma. The company’s stock has a 52-week low of $52.65.
  • RSI Value: 29.33
  • AZN Price Action: Shares of AstraZeneca rose 0.3% to trade at $63.34 on Friday.
Pfizer Inc. (NYSE: PFE)
  • Pfizer reported a Q4 adjusted EPS of $1.14, up 45% Y/Y, well ahead of the consensus of $1.05. The company’s stock has a 52-week low of $41.45.
  • RSI Value: 28.78
  • PFE Price Action: Shares of Pfizer fell 0.9% to trade at $43.97 on Friday.
Amgen Inc. (NASDAQ: AMGN)
  • US approved AstraZeneca, Amgen's Tezspire (tezepelumab) for self-administration in a pre-filled, single-use pen for patients 12 years and older with severe asthma. The company’s 52-week low is $214.39.
  • RSI Value: 23.51
  • AMGN Price Action: Shares of Amgen fell 0.9% to trade at $244.30 on Friday.
1Life Healthcare, Inc. (NASDAQ: ONEM)
  • 1Life Healthcare, during November, posted a Q3 loss of $0.57 per share. The company has a 52-week low of $5.94.
  • RSI Value: 20.69
  • ONEM Price Action: Shares of 1Life Healthcare dropped 3% to trade at $15.15 on Friday.
Read More: $10 Million Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Buying

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.